3D image of a stent inside a coronary artery taken using the Ilumien Optis. Photo: Courtesy of St Jude Medical, Inc.
Medical devices major St Jude Medical has obtained European approval for its 3D vessel reconstruction technology, which helps in assessing the condition of arteries to treat patients with coronary artery disease (CAD).
The Ilumien Optis percutaneous coronary intervention (PCI) optimisation system is believed to aid physicians in stent placement by providing a real-time 360° panoramic view of the arteries in 3D.
With CE Mark approval in place, the company is set to display the tool in for the first time in Europe during EuroPCR, the official congress of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Commenting on the development, Ospedale Papa Giovanni XXIII Cardiovascular Department’s Dr Giulio Guagliumi said the OCT technology is gaining significance in diagnosing and treating CAD patients.
“The Ilumien Optis system is a significant advancement in intravascular imaging technology allowing physicians to comprehensively assess more vessel in less time and more easily plan their PCI procedure,” Guagliumi said.
Source: www.medicaldevice-network.com; May 17, 2013.
